Printer Friendly

Articles from Chain Drug Review (December 7, 2009)

1-99 out of 99 article(s)
Title Author Type Words
'Health care reform should include drug benefits'. Clinical report 214
'It's the season to save' with ExtraCare card. 476
A one-stop resource for holiday shoppers. 674
Adjusted income up 15.5% at Cardinal in first quarter. Financial report 753
Advanced technology facilitates health care delivery. 391
AG unveils slide show cards. 345
Alberta pharmacy strategy advances. 564
Amid reform, provinces enlarge the role of community RX. Conference news 745
An opportunity realized. Coopman, Robert 503
Analysts still bullish on growth outlook. Financial report 662
Assimilation of Longs occurs without a hitch. 704
Assisting children a top priority. 350
Bang to leave post at Walgreens. Brief article 192
CDC: many people lax on health screenings. Brief article 106
CE catalog highlights. 444
Celgene agrees to acquire Gloucester. Brief article 303
Chain drug sales solid in November. Brief article 289
Changes in works at PBM division. Brief article 248
Clinton, Bush to appear at BIO convention in May. Brief article 244
CMS policy on Part D is at issue. 423
Collaborative approach gets good results. Brief article 171
Combination of health care, value is main focus. 768
CVS Caremark makes difference in people's lives. 568
CVS Caremark's retail business 'strong and growing'. 900
CVS enhances shopping experience at former Longs units. 637
CVS leverages learnings to sharpen merchandising. 671
CVS pharmacy care is second to none. 496
CVS shows its mettle in winning the battle for Longs. Financial report 868
CVS strives to be 'even better'. 858 adds new capabilities. 373
CVS/pharmacy ready to seize opportunities. Brief article 202
Deal enhances health care services. Brief article 186
Denton to succeed Rickard in CFO slot. Brief article 175
Despite recent hiccup, PBM has great potential. 579
Drug chains seen as growth channel for snack foods. White, Roy 858
Drug pricing probe sought. 481 has best day ever. Brief article 195
Duane Reade 'pleased with momentum of its business'. Financial report 1336
Employers eye medication adherence. 401
Expansion plans lean toward organic growth. 436
Expectations for fiscal year lowered in two key areas. Brief article 269
Feminine care line has Moxie. Brief article 148
Full senate takes up debate about health care reform. 636
Governments fight counterfeit drugs. Brief article 215
GSK issues warning about a batch of HIN1 vaccine in Canada. 567
Headway made in cancer medications. 586
Health care outlays in Canada to rise. Statistical data 525
Hershey expands its Bliss chocolate line. Brief article 225
Incidence of swine flu cases abating. 617
Medco plans to invest in gene studies. 348
Milestone achieved in chain's relentless expansion. 508
MinuteClinic is helping to close gap in primary care. 689
NACDS in N.Y.C. Brief article 175
NACDS is hub of chain drug industry. Pinto, David 789
New president, COO settles in. Brief article 175
Newest version of photo service via Internet makes debut. 368
No slowdown seen for surging retail business. Financial report 381
Novartis launches its first U.S. flu vaccine plant. Brief article 327
Offer wins notice in Bay Area. Brief article 241
Orexigen adds four seasoned executives to management team. 374
PBM/retail combination changes the game in Rx. 765
PEDiNOL launches over-the-counter Lactinol moisturizer. Brief article 156
Perrigo labels will show 'gluten-free'. Brief article 191
Pfizer takes new direction with Protalix pact. 584
Pharmacist's efforts recognized. Brief article 286
Plan design can raise utilization of generics. Brief article 246
Plan improves Rx compliance. Brief article 170
Report shines light on specialty meds. 312
Research to assess Rxs for children. Brief article 180
Retail pharmacist takes proactive approach. 667
Rogue Web pharmacies draw fire from NACDS. Brief article 217
Rx makers scrutinizing their sales strategies. Brief article 214
RxSchool live online CE. 238
SAD is real, and treatable. Agins, Alan 786
Sales, earnings climb by double digits in third quarter. Financial report 1160
SDM net rises 6.6% on a 7.9% sales increase. Financial report 635
Senate reform bill blasted by GPhA. 539
Seniors get helping hand with Medicare Part D. 402
Spurt of acquisitions vaults company to the top. 438
Store formats to reflect market clusters. Brief article 305
Stores are in sync with the green movement. 451
STR helps retailers build store brands. Brief article 170
Strong performance clouded by PBM guidance. Brief article 335
Study backs efficacy of clinics. Brief article 293
Study backs efficacy of simvastatin. Report 449
Study: doctor/Rx teams are effective. 437
Study: taxing times ahead. 477
Suppliers post solid earnings. Financial report 2045
Support provided for ALS research. Brief article 178
Three plan to leave board at Walgreens. Brief article 236
Two more generics gain FDA approval. Brief article 253
Venter Institute appoints Nelson to succeed Strausberg. 495
Walgreens enhances its web site. 354
Walgreens exec ranks undergo more shifts. 577
Watson wraps up its Acquisition of Arrow Group. 370
West Coast consumers like what they see. 422
What science-based guidelines mean for Rx. Woldt, Jeffrey 552
Xenna rolls out exfoliating gel. Brief article 296
Zegerid OTC set to hit drug stores next year. Brief article 163

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters